This variability reflects differences in vascular anatomy, injection technique consistency, and individual clotting factors
(Eli Lilly, which makes another GLP-1 drug, tirzepatide, was also included in the lawsuit.) The new research, based on health insurance claims from 2006 to 2020 from more than 5,000 patients in the U.S., looked at how many people developed one of four serious gastrointestinal problems biliary disease, gastroparesis, pancreatitis or bowel obstructions after they were prescribed one of the weight loss drugs
Reputable telehealth services should require comprehensive medical histories, laboratory results, and ongoing monitoring
Tirzepatide, which acts on both GIP and GLP-1 receptors, appears to have a somewhat more favorable GI tolerability profile, possibly because GIP receptor activation partially counteracts the nausea-inducing effects of GLP-1 agonism
FDA is aware that compounders provide semaglutide in various concentrations
While Rybelsus can contribute to weight loss, its primary purpose is to help manage blood sugar levels in diabetes patients
